|
NL297170A
(pl)
|
1963-04-04 |
1900-01-01 |
|
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
WO1999000113A1
(en)
|
1997-06-27 |
1999-01-07 |
Vivorx Pharmaceuticals, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
GB9312853D0
(en)
|
1993-06-22 |
1993-08-04 |
Euro Celtique Sa |
Chemical compounds
|
|
EP0944388A4
(en)
|
1996-04-03 |
2001-08-16 |
Merck & Co Inc |
INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
|
|
US6432947B1
(en)
|
1997-02-19 |
2002-08-13 |
Berlex Laboratories, Inc. |
N-heterocyclic derivatives as NOS inhibitors
|
|
WO1999007703A1
(en)
|
1997-08-05 |
1999-02-18 |
Pfizer Products Inc. |
4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
|
|
US6162804A
(en)
|
1997-09-26 |
2000-12-19 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
AU4231299A
(en)
|
1998-06-04 |
1999-12-20 |
Abbott Laboratories |
Cell adhesion-inhibiting antinflammatory compounds
|
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
|
US6262066B1
(en)
|
1998-07-27 |
2001-07-17 |
Schering Corporation |
High affinity ligands for nociceptin receptor ORL-1
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
HK1045306A1
(zh)
|
1999-06-03 |
2002-11-22 |
Abbott Laboratories |
抑制细胞黏附的抗炎化合物
|
|
US7160890B2
(en)
|
1999-12-02 |
2007-01-09 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
OA12292A
(en)
|
2000-06-26 |
2003-11-11 |
Pfizer Prod Inc |
PyrroloÄ2,3-dÜpyrimidine compounds as immunosuppressive agents.
|
|
KR100602929B1
(ko)
|
2000-08-31 |
2006-07-20 |
에프. 호프만-라 로슈 아게 |
알파-1 아드레날린성 길항제로서 퀴나졸린 유도체
|
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
BR0115847A
(pt)
|
2000-12-01 |
2004-02-25 |
Osi Pharm Inc |
Compostos especìficos para receptor para adenosina a1, a2a, e a3 e usos dos mesmos
|
|
US6673802B2
(en)
|
2000-12-01 |
2004-01-06 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
UY27220A1
(es)
*
|
2001-03-23 |
2002-09-30 |
Aventis Pharma Sa |
Combinación de un taxano con una quinasa ciclina-dependiente
|
|
DE60305446T4
(de)
|
2002-01-07 |
2009-07-09 |
Eisai R&D Management Co., Ltd. |
Desazapurine und deren verwendung
|
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
|
NZ535992A
(en)
*
|
2002-05-17 |
2008-11-28 |
Aventis Pharma Sa |
Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
|
|
DK1522314T3
(da)
|
2002-06-26 |
2014-05-26 |
Ono Pharmaceutical Co |
Midler for sygdomme forårsaget af vaskulær sammentrækning eller udvidelse
|
|
US20040138238A1
(en)
|
2002-08-08 |
2004-07-15 |
Dhanoa Dale S. |
Substituted aminopyrimidine compounds as neurokinin antagonists
|
|
US20030139427A1
(en)
|
2002-08-23 |
2003-07-24 |
Osi Pharmaceuticals Inc. |
Bicyclic pyrimidinyl derivatives and methods of use thereof
|
|
WO2004021979A2
(en)
|
2002-09-06 |
2004-03-18 |
Smithkline Beecham Corporation |
PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS
|
|
US20060159617A1
(en)
|
2002-11-08 |
2006-07-20 |
Ashfaq Mahmood |
Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
|
|
AU2003302657B8
(en)
|
2002-12-04 |
2009-12-03 |
Eisai R&D Management Co., Ltd. |
Fused 1,3-dihydroimidazole ring compounds
|
|
EP1444982A1
(de)
|
2003-02-06 |
2004-08-11 |
Merckle Gmbh |
Verwendung von Purinderivaten als selektive Kinase-Inhibitoren
|
|
MXPA05009722A
(es)
|
2003-03-10 |
2006-03-09 |
Schering Corp |
Inhibidores heterociclicos de cinasa: metodos de uso y sintesis.
|
|
AU2004232392A1
(en)
|
2003-04-21 |
2004-11-04 |
Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky |
(Purin-6-yl) amino acid and production method thereof
|
|
FR2856685B1
(fr)
|
2003-06-25 |
2005-09-23 |
Merck Sante Sas |
Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
|
WO2005020921A2
(en)
|
2003-08-29 |
2005-03-10 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
|
TW200526626A
(en)
|
2003-09-13 |
2005-08-16 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2004293026B2
(en)
|
2003-11-21 |
2012-01-19 |
Array Biopharma Inc. |
AKT protein kinase inhibitors
|
|
WO2005063704A1
(ja)
|
2003-12-25 |
2005-07-14 |
Ono Pharmaceutical Co., Ltd. |
アゼチジン環化合物およびその医薬
|
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
|
AU2005322085B2
(en)
|
2004-12-28 |
2012-07-19 |
Exelixis, Inc. |
[1H-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70S6K, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
|
|
FR2880626B1
(fr)
|
2005-01-13 |
2008-04-18 |
Aventis Pharma Sa |
Derives de la purine, compositions les contenant et utilisation
|
|
FR2880540B1
(fr)
|
2005-01-13 |
2008-07-11 |
Aventis Pharma Sa |
Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90
|
|
US7423043B2
(en)
|
2005-02-18 |
2008-09-09 |
Lexicon Pharmaceuticals, Inc. |
4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds
|
|
US20060281768A1
(en)
|
2005-06-10 |
2006-12-14 |
Gaul Michael D |
Thienopyrimidine and thienopyridine kinase modulators
|
|
JP5071374B2
(ja)
|
2005-07-14 |
2012-11-14 |
アステラス製薬株式会社 |
ヘテロ環ヤヌスキナーゼ３阻害剤
|
|
US20070049591A1
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Inhibitors of MAPK/Erk Kinase
|
|
CN101291658B
(zh)
|
2005-08-31 |
2014-04-16 |
阿布拉科斯生物科学有限公司 |
用于制备稳定性增加的水难溶性药物的组合物和方法
|
|
US7771751B2
(en)
|
2005-08-31 |
2010-08-10 |
Abraxis Bioscience, Llc |
Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
|
|
WO2007084667A2
(en)
|
2006-01-19 |
2007-07-26 |
Osi Pharmaceutical, Inc. |
Fused heterobicyclic kinase inhibitors
|
|
JP2009534454A
(ja)
|
2006-04-25 |
2009-09-24 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
EP2037931A2
(en)
|
2006-04-25 |
2009-03-25 |
Astex Therapeutics Limited |
Pharmaceutical combinations of pk inhibitors and other active agents
|
|
WO2007125321A2
(en)
|
2006-04-25 |
2007-11-08 |
Astex Therapeutics Limited |
Purine and deazapurine derivatives as pharmaceutical compounds
|
|
JP2009534456A
(ja)
|
2006-04-25 |
2009-09-24 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
US20090253718A1
(en)
|
2006-04-25 |
2009-10-08 |
Astex Therapeutics Limited |
Pharmaceutical Compounds
|
|
US8828451B2
(en)
*
|
2006-10-04 |
2014-09-09 |
University Of South Florida |
Akt sensitization of cancer cells
|
|
AR064415A1
(es)
|
2006-12-21 |
2009-04-01 |
Cancer Rec Tech Ltd |
Derivados de pirrolo-piperidinas y purinas,composiciones farmaceuticas que los contienen y usos en trastornos y/o enfermedades mediadas por pka y pkb.
|
|
AR064416A1
(es)
|
2006-12-21 |
2009-04-01 |
Cancer Rec Tech Ltd |
Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
|
|
WO2008079346A1
(en)
|
2006-12-21 |
2008-07-03 |
Vertex Pharmaceuticals Incorporated |
5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
|
BRPI0818533B8
(pt)
*
|
2007-10-11 |
2021-05-25 |
Astrazeneca Ab |
composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
|
|
ME03589B
(me)
*
|
2011-04-01 |
2020-07-20 |
Astrazeneca Ab |
Terapeutski tretman
|